(VIANEWS) - Caesarstone Ltd. (CSTE), Cyclacel Pharmaceuticals (CYCCP), NRG Energy (NRG) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Caesarstone Ltd. (CSTE) | 13.12 | 0.54% | 6.4% | 2021-07-25 21:49:05 |
| 2 | Cyclacel Pharmaceuticals (CYCCP) | 11.00 | 18.79% | 5.45% | 2021-07-25 22:42:05 |
| 3 | NRG Energy (NRG) | 41.15 | 1.08% | 3.53% | 2021-07-28 15:55:51 |
| 4 | Kimco Realty Corporation (KIM) | 20.81 | 1.07% | 3.28% | 2021-07-24 19:11:25 |
| 5 | Packaging Corporation of America (PKG) | 133.63 | 1.6% | 2.99% | 2021-07-25 03:06:05 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Caesarstone Ltd. (CSTE) - Dividend Yield: 6.4%
Caesarstone Ltd., together with its subsidiaries, develops, manufactures, and markets engineered quartz surfaces under the Caesarstone brand in the United States, Australia, Canada, Israel, Europe, and internationally. Its engineered quartz slabs are primarily used as kitchen countertops in the renovation and remodeling markets, as well as in new buildings construction market. The company's products are also used in other applications, such as vanity tops, wall panels, back splashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. It sells its products directly to fabricators, sub-distributors, and resellers; and indirectly through a network of independent distributors. The company was formerly known as Caesarstone Sdot Yam Ltd. and changed its name to Caesarstone Ltd. in June 2016. Caesarstone Ltd. was founded in 1987 and is headquartered in MP Menashe, Israel.
Volume
Today's last reported volume for Caesarstone Ltd. is 46682, 66.73% below its average volume of 140322.
Caesarstone Ltd.'s last close was $13.12, 33.74% below its 52-week high of $19.80.
Caesarstone Ltd.'s Sales
Caesarstone Ltd.'s sales growth is 47.1% for the present quarter and 27% for the next. The company's growth estimates for the ongoing quarter is a negative 50% and positive 30.8% for the next.
Caesarstone Ltd.'s Revenue
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 505.89M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Caesarstone Ltd.'s stock is considered to be oversold (<=20).
Caesarstone Ltd.'s Stock Yearly Top and Bottom Value
Caesarstone Ltd.'s stock is valued at $13.12 at 20:15 EST, way under its 52-week high of $19.80 and way higher than its 52-week low of $9.23.
Caesarstone Ltd.'s Moving Average
Caesarstone Ltd.'s worth is below its 50-day moving average of $14.57 and under its 200-day moving average of $14.17.More news about Caesarstone Ltd..
2. Cyclacel Pharmaceuticals (CYCCP) - Dividend Yield: 5.45%
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include CYC065, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise sapacitabine, an oral nucleoside analogue prodrug that is in Phase 1/2 combination study with seliciclib, a CDK inhibitor in patients with BRCA mutations; with olaparib, a poly ADP-ribose polymerase inhibitor in BRCA mutation positive patients with breast cancer; and Phase III clinical trial for the treatment of acute myeloid leukemia. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor that is in all-oral Phase 1/2 combination study with sapacitabine for BRCA mutations. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias; and collaboration, licensing, and supply agreement with ManRos Therapeutics SA for the development and commercialization of oral seliciclib capsules for the treatment of cystic fibrosis. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.
Volume
Today's last reported volume for Cyclacel Pharmaceuticals is 3, 98.7% below its average volume of 230.
Cyclacel Pharmaceuticals's last close was $11.00, 1.52% under its 52-week high of $11.17.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Cyclacel Pharmaceuticals's stock is considered to be oversold (<=20).
Cyclacel Pharmaceuticals's Stock Yearly Top and Bottom Value
Cyclacel Pharmaceuticals's stock is valued at $11.00 at 20:15 EST, under its 52-week high of $11.17 and way above its 52-week low of $4.85.
Cyclacel Pharmaceuticals's Moving Average
Cyclacel Pharmaceuticals's worth is way above its 50-day moving average of $9.92 and way higher than its 200-day moving average of $8.76.More news about Cyclacel Pharmaceuticals.
3. NRG Energy (NRG) - Dividend Yield: 3.53%
NRG Energy, Inc., together with its subsidiaries, operates as an energy company in the United States. It operates through Generation and Retail segments. The company is involved in the producing, selling, and delivering electricity and related products and services to 3.7 million residential, industrial, and commercial consumers. It generates electricity using natural gas, coal, oil, solar, nuclear, and battery storage. The company also provides system power, distributed generation, renewable products, backup generation, storage and distributed solar, demand response, energy efficiency, advisory, and on-site energy solutions; and carbon management and specialty services. In addition, it trades in electric power, natural gas, and related commodity and financial products, including forwards, futures, options, and swaps. Further, the company procures fuels; provides transportation services; and directly sells energy, services, and products and services to retail customers under the NRG, Reliant, Green Mountain Energy, Stream, XOOM Energy, and other names. As of December 31, 2019, it owns fossil fuel, nuclear, and renewable plants with generation capacity of 23,000 megawatts. NRG Energy, Inc. was founded in 1989 and is headquartered in Princeton, New Jersey.
Volume
Today's last reported volume for NRG Energy is 1733530, 43.3% below its average volume of 3057200.
NRG Energy's last close was $41.00, 6.99% under its 52-week high of $44.08.
The company's growth estimates for the ongoing quarter and the next is 15% and 129.4%, respectively.NRG Energy's Revenue
Year-on-year quarterly revenue growth grew by 300.7%, now sitting on 15.16B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,NRG Energy's stock is considered to be oversold (<=20).
NRG Energy's Stock Yearly Top and Bottom Value
NRG Energy's stock is valued at $41.15 at 20:15 EST, below its 52-week high of $44.08 and way above its 52-week low of $28.22.
NRG Energy's Moving Average
NRG Energy's worth is above its 50-day moving average of $39.09 and above its 200-day moving average of $38.35.More news about NRG Energy.
4. Kimco Realty Corporation (KIM) - Dividend Yield: 3.28%
Kimco Realty Corp. (NYSE:KIM) is a real estate investment trust (REIT) headquartered in Jericho, N.Y. that is one of North America's largest publicly traded owners and operators of open-air, grocery-anchored shopping centers and mixed-use assets. As of June 30, 2020, the company owned interests in 400 U.S. shopping centers and mixed-use assets comprising 70 million square feet of gross leasable space primarily concentrated in the top major metropolitan markets. Publicly traded on the NYSE since 1991, and included in the S&P 500 Index, the company has specialized in shopping center acquisitions, development and management for more than 60 years.
Volume
Today's last reported volume for Kimco Realty Corporation is 3357160, 29.4% below its average volume of 4755430.
Kimco Realty Corporation's last close was $20.81, 6.72% under its 52-week high of $22.31.
Kimco Realty Corporation's Sales
Kimco Realty Corporation's sales growth is 15.3% for the present quarter and 7.1% for the next. The company's growth estimates for the present quarter is a negative 93% and positive 210% for the next.
Kimco Realty Corporation's Revenue
Year-on-year quarterly revenue growth declined by 2.6%, now sitting on 1.05B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Kimco Realty Corporation's stock is considered to be oversold (<=20).
Kimco Realty Corporation's Stock Yearly Top and Bottom Value
Kimco Realty Corporation's stock is valued at $20.81 at 20:15 EST, below its 52-week high of $22.31 and way above its 52-week low of $10.04.
Kimco Realty Corporation's Moving Average
Kimco Realty Corporation's worth is below its 50-day moving average of $21.14 and higher than its 200-day moving average of $19.40.More news about Kimco Realty Corporation.
5. Packaging Corporation of America (PKG) - Dividend Yield: 2.99%
Packaging Corporation of America manufactures and sells containerboard and corrugated packaging products in the United States. The company operates through Packaging and Paper segments. The Packaging segment offers various containerboard and corrugated packaging products, such as conventional shipping containers used to protect and transport manufactured goods; multi-color boxes and displays that help to merchandise the packaged product in retail locations; and honeycomb protective packaging products, as well as packaging for meat, fresh fruit and vegetables, processed food, beverages, and other industrial and consumer products. This segment sells its corrugated products through a direct sales and marketing organization, independent brokers, and distribution partners. The Paper segment manufactures and sells commodity and specialty papers, as well as communication-based papers, such as cut-size office papers, and printing and converting papers. This segment sells white papers through its sales and marketing organization. Packaging Corporation of America was founded in 1867 and is headquartered in Lake Forest, Illinois.
Volume
Today's last reported volume for Packaging Corporation of America is 481465, 13.16% below its average volume of 554415.
Packaging Corporation of America's last close was $133.63, 14.64% below its 52-week high of $156.54.
The company's growth estimates for the current quarter and the next is 28.3% and 33.8%, respectively.Packaging Corporation of America's Revenue
Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 6.76B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Packaging Corporation of America's stock is considered to be oversold (<=20).
Packaging Corporation of America's Stock Yearly Top and Bottom Value
Packaging Corporation of America's stock is valued at $133.63 at 20:15 EST, way below its 52-week high of $156.54 and way higher than its 52-week low of $92.02.
Packaging Corporation of America's Moving Average
Packaging Corporation of America's value is below its 50-day moving average of $136.81 and below its 200-day moving average of $139.67.More news about Packaging Corporation of America.